High plasma serotonin levels in primary pulmonary hypertension: Effect of long-term epoprostenol (Prostacyclin) therapy

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 10, 2000, Pages 2233-2239

  Kereveur A ^a   Callebert, J ^a   Humbert, M ^b   Herve P ^c   Simonneau, G ^b   Launay, J M ^a   Drouet, Ludovic ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

Epoprostenol; Platelet activation; Primary pulmonary hypertension; Prostacyclin; Serotoni

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ANOREXIGENIC AGENT; CD36 ANTIGEN; CD63 ANTIGEN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN; PADGEM PROTEIN; PROSTACYCLIN; SEROTONIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HEMODYNAMICS; HUMAN; LONG TERM CARE; LUNG RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SEROTONIN BLOOD LEVEL; THROMBOCYTE ACTIVATION;

EID: 0033789253     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.10.2233     Document Type: Article

References (39)

1. Mapping of familial primary pulmonary hypertension locus (PPHI) to chromosome 2q31-q32
2. Pulmonary hypertension and dexfenfluramine
3. Pulmonary hypertension and fenfluramine
4. Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine
5. Pulmonary hypertension and defenfluramine
6. Primary pulmonary hypertension: Vascular structure, morphometry, and responsiveness to vasodilator agents
7. The role of thrombosis in severe pulmonary hypertension
8. Primary pulmonary hypertension
9. Pulmonary hypertension, anorexigens and 5-HT: Pharmacological synergism in action?
10. Amine storage organalles in platelets
11. Effects of serotonin on platelet activation in whole blood
12. Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: Role of serotonin
13. Increased plasma serotonin in primary pulmonary hypertension
14. Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine
15. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
16. Alpha-granule pool of glycoprotein IIb-IIIa in normal and pathological platelets and megakaryocytes
17. Platelet activation results in a redistribution of glycoprotein IV (CD36)
18. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation
19. Studies with a monoclonal antibody against activated platelets: Evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation
20. The measurement of 5-hydroxyindoleacetic acid in urine
21. A modified enzymatic-isotopic microassay for serotonin (5-HT) using 5-HT-N-acetyltransferase partially purified from Drosophila
22. Absence of serotoninergic innervation from raphe nuclei in rat cerebral blood vessels, II: Lack of tryptophan hydroxylase activity in vitro
23. Circulating activated platelets in myeloproliferative disorders
24. On the accurate determination of serotonin in human plasma
25. A new role for an old molecule: Serotonin as a mitogen
26. 5-Hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: Importance of the 5-HT1B receptor
27. Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine
28. Endothelial dysfunction in pulmonary hypertension
29. Plasma levels of thrombomodulin in pulmonary hypertension
30. Continuous infusion of prostacyclin decreases plasma levels of t-PA and PAI-1 in primary pulmonary hypertension
31. Endothelin-1 in primary pulmonary hypertension and eisenmenger syndrome
32. An imbalance between excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension
33. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension
34. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
35. Flow cytometry: A clinical test of platelet function
36. In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function
37. The pulmonary hypertensive fawn-hooded rat has a normal serotonin transporter coding sequence
38. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells: Relationship with the mitogenic action of serotonin
39. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension